Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC
Clinical trial NCT04153734 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04153734
- Sponsor
- Kobe Minimally Invasive Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2021-11-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.